Suchergebnisse - "Wang, Yixin"

PubPharm (5)

1

Correction to Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

enthalten in: Molecular pharmaceutics | 2020

von Cao, H. | Wang, Y. | He, X. | +9

ErratumFor: Mol Pharm. 2015 Mar 2;12(3):922-31. - PMID 25622075

2

Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma

enthalten in: Molecular pharmaceutics | 2015

von Cao, H. | Wang, Y. | He, X. | +9

ErratumIn: Mol Pharm. 2020 Jan 6;17(1):359. - PMID 31802672

3

Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma

enthalten in: Molecular pharmaceutics | 2015

von Cao, H. | Wang, Y. | He, X. | +9

4

Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine

enthalten in: Molecular pharmaceutics | 2013

von Zhang, Z. | Liu, Z. | Ma, L. | +6

5

Reversal of Multidrug Resistance by Mitochondrial Targeted Self-Assembled Nanocarrier Based on Stearylamine

enthalten in: Molecular pharmaceutics | 2013

von Zhang, Z. | Liu, Z. | Ma, L. | +6

1
[1]